Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Discover which index funds are top rated for retirement in 2024 and why they matter for your portfolio. Learn about performance, fees, and diversification.
25,383 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
The World Cup sticker craze is rising in the United States as fans stock up on Panini packs. This year’s North Americ...
Banking offers for new checking accounts are surging in mid-2026 as lenders chase deposits. This guide explains how t...
Tensions flare in the Persian Gulf as tit-for-tat attacks continue across the region despite a tentative U.S.-Iran ce...
As of July 8, 2026, investors are weighing how a $300,000 portfolio can yield steady monthly income. Three clear path...
As AMD gears up for its July 22 AI event, traders are weighing the risk and reward. This article outlines why the set...
First Trust AIRR, a small-cap industrial-focused ETF, has surged in 2026 and boasts a five-year performance well ahea...
When a celebrity’s home is hit by gunfire in broad daylight, the headlines tell a story of fear. This article transla...
VR Adviser recently disclosed a substantial sale of Ocular Therapeutix shares, triggering questions about what it mea...
Defiance’s 2X inverse ETF tied to SMCI confronts a classic risk now that SMCI has reported after hours. The fund’s da...
Investing in AI memory and storage chips may beat chasing hype. Learn how to spot the driver, assess risk, and start ...
Bitcoin dropped about $2,000 in minutes after a prominent political figure signaled unwavering support for crypto, tr...